T cells and autoimmune disease

An update to the Autoimmune diseases–prevention and control bibliography; this article has been added to the bibliography and to the Science Primary Literature Database.

Featured article:

*Lee, D. J. (2020). The relationship between TIGIT+ regulatory T cells and autoimmune disease. International Immunopharmacology, 83, 1. [Cited by]

The role of regulatory T cells (Treg cell) in controlling autoimmune disease is an area of intense study. As such, the characterization and understanding the function of Treg markers has the potential to provide a considerable impact in developing treatments and understanding the pathogenesis of autoimmune diseases. One such inhibitory Treg cell marker that has been recently discovered is T cell immunoglobulin and ITIM domain (TIGIT). In this review, we discuss what is known about the expression and function of TIGIT on Treg cells, and we discuss the relationship between TIGIT expressing Treg cells and different autoimmune diseases such as atopic dermatitis, autoimmune thyroiditis, type 1 diabetes, autoimmune uveitis, aplastic anemia, multiple sclerosis, systemic lupus erythematosus, arthritis, and colitis.

Questions? Please let me know (engelk@grinnell.edu).

Was this helpful?

This site uses Akismet to reduce spam. Learn how your comment data is processed.